Robert Herman Shmerling, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Infectious | 9 | 2021 | 367 | 1.530 |
Why?
|
Antibodies, Antinuclear | 6 | 2022 | 326 | 1.490 |
Why?
|
Gout | 8 | 2022 | 573 | 1.420 |
Why?
|
Arthritis, Rheumatoid | 14 | 2017 | 3712 | 1.140 |
Why?
|
Antirheumatic Agents | 8 | 2017 | 1339 | 0.900 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2022 | 2104 | 0.890 |
Why?
|
Peptides, Cyclic | 3 | 2014 | 400 | 0.770 |
Why?
|
Diagnostic Tests, Routine | 2 | 2019 | 783 | 0.750 |
Why?
|
Gout Suppressants | 4 | 2018 | 166 | 0.680 |
Why?
|
Chondrocalcinosis | 2 | 2018 | 79 | 0.650 |
Why?
|
Prosthesis-Related Infections | 2 | 2021 | 538 | 0.620 |
Why?
|
Rheumatoid Factor | 7 | 2014 | 188 | 0.610 |
Why?
|
Arthritis | 4 | 2018 | 659 | 0.600 |
Why?
|
False Positive Reactions | 1 | 2019 | 981 | 0.570 |
Why?
|
Curettage | 1 | 2016 | 73 | 0.550 |
Why?
|
Synovial Fluid | 5 | 2021 | 394 | 0.520 |
Why?
|
Fibromyalgia | 3 | 2010 | 388 | 0.510 |
Why?
|
Rheumatology | 4 | 2017 | 576 | 0.510 |
Why?
|
Independent Living | 5 | 2019 | 568 | 0.450 |
Why?
|
Debridement | 1 | 2016 | 492 | 0.450 |
Why?
|
Rheumatic Diseases | 5 | 2005 | 592 | 0.440 |
Why?
|
Arthritis, Gouty | 1 | 2012 | 28 | 0.440 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2013 | 349 | 0.410 |
Why?
|
Common Cold | 1 | 2011 | 61 | 0.380 |
Why?
|
Laboratories | 1 | 2014 | 463 | 0.380 |
Why?
|
Eructation | 1 | 2010 | 5 | 0.380 |
Why?
|
Critical Pathways | 1 | 2014 | 476 | 0.380 |
Why?
|
Blood Sedimentation | 4 | 2014 | 231 | 0.360 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2133 | 0.360 |
Why?
|
Giant Cell Arteritis | 2 | 2006 | 292 | 0.360 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1462 | 0.360 |
Why?
|
Hyperpigmentation | 1 | 2011 | 112 | 0.350 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1458 | 0.350 |
Why?
|
Mucus | 1 | 2011 | 321 | 0.350 |
Why?
|
Osteoarthritis | 5 | 2011 | 1036 | 0.340 |
Why?
|
Clinical Laboratory Techniques | 1 | 2014 | 738 | 0.340 |
Why?
|
Eyelids | 1 | 2011 | 265 | 0.330 |
Why?
|
Xanthomatosis, Cerebrotendinous | 1 | 2008 | 9 | 0.330 |
Why?
|
Nasal Mucosa | 1 | 2011 | 373 | 0.320 |
Why?
|
Joints | 3 | 2016 | 326 | 0.310 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2002 | 288 | 0.300 |
Why?
|
Cold Temperature | 1 | 2011 | 772 | 0.300 |
Why?
|
Methotrexate | 2 | 2014 | 1727 | 0.300 |
Why?
|
Glucocorticoids | 3 | 2015 | 2107 | 0.290 |
Why?
|
Prednisone | 2 | 2018 | 1574 | 0.290 |
Why?
|
Edema | 1 | 2011 | 789 | 0.290 |
Why?
|
Tai Ji | 1 | 2010 | 285 | 0.290 |
Why?
|
Eye Diseases | 1 | 2011 | 669 | 0.260 |
Why?
|
Uric Acid | 4 | 2022 | 766 | 0.260 |
Why?
|
Disability Evaluation | 3 | 2019 | 1827 | 0.240 |
Why?
|
Autoantibodies | 2 | 2022 | 2035 | 0.240 |
Why?
|
Evidence-Based Medicine | 3 | 2015 | 3610 | 0.240 |
Why?
|
Complementary Therapies | 1 | 2008 | 486 | 0.230 |
Why?
|
Pain Measurement | 7 | 2019 | 3420 | 0.230 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2004 | 214 | 0.220 |
Why?
|
Postural Balance | 5 | 2015 | 620 | 0.220 |
Why?
|
Humans | 76 | 2022 | 744343 | 0.220 |
Why?
|
Glucosamine | 1 | 2002 | 132 | 0.210 |
Why?
|
Chondroitin Sulfates | 1 | 2002 | 187 | 0.210 |
Why?
|
Transaminases | 1 | 2003 | 199 | 0.210 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9274 | 0.210 |
Why?
|
Staphylococcal Infections | 3 | 2021 | 1400 | 0.210 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2011 | 3923 | 0.200 |
Why?
|
Counseling | 1 | 2009 | 1523 | 0.200 |
Why?
|
S-Adenosylmethionine | 1 | 2002 | 212 | 0.200 |
Why?
|
Creatine Kinase | 1 | 2003 | 694 | 0.190 |
Why?
|
Exercise Therapy | 1 | 2008 | 906 | 0.190 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7913 | 0.180 |
Why?
|
Immunologic Tests | 1 | 2021 | 103 | 0.180 |
Why?
|
Breast Implants | 1 | 2003 | 387 | 0.180 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 3255 | 0.170 |
Why?
|
Melanoma | 1 | 2018 | 5510 | 0.170 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5686 | 0.160 |
Why?
|
Vasculitis | 1 | 2002 | 519 | 0.160 |
Why?
|
Mobility Limitation | 3 | 2019 | 409 | 0.160 |
Why?
|
Osteomyelitis | 1 | 2021 | 402 | 0.150 |
Why?
|
Cognition | 2 | 2014 | 6770 | 0.150 |
Why?
|
Serologic Tests | 2 | 2014 | 374 | 0.150 |
Why?
|
Pain | 4 | 2016 | 4986 | 0.140 |
Why?
|
Biological Products | 2 | 2015 | 860 | 0.140 |
Why?
|
Bursitis | 1 | 2017 | 83 | 0.140 |
Why?
|
Retrospective Studies | 16 | 2021 | 77449 | 0.140 |
Why?
|
Colchicine | 2 | 2018 | 243 | 0.140 |
Why?
|
Hypertension | 2 | 2020 | 8480 | 0.140 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1996 | 428 | 0.130 |
Why?
|
Anticholesteremic Agents | 1 | 2003 | 979 | 0.130 |
Why?
|
Pregnancy Complications | 1 | 2009 | 2861 | 0.130 |
Why?
|
Fingers | 2 | 1988 | 513 | 0.130 |
Why?
|
Middle Aged | 28 | 2022 | 213383 | 0.130 |
Why?
|
Pain Perception | 1 | 2016 | 191 | 0.130 |
Why?
|
Musculoskeletal System | 2 | 2009 | 175 | 0.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 687 | 0.130 |
Why?
|
Endocarditis, Bacterial | 1 | 2019 | 455 | 0.130 |
Why?
|
Male | 39 | 2022 | 350118 | 0.120 |
Why?
|
Aged | 33 | 2022 | 163280 | 0.120 |
Why?
|
Sensitivity and Specificity | 7 | 2013 | 14722 | 0.120 |
Why?
|
Arthralgia | 3 | 2018 | 456 | 0.120 |
Why?
|
Aged, 80 and over | 19 | 2020 | 57776 | 0.120 |
Why?
|
Anti-Bacterial Agents | 3 | 2021 | 7181 | 0.120 |
Why?
|
Geriatric Assessment | 2 | 2019 | 1372 | 0.110 |
Why?
|
Predictive Value of Tests | 7 | 2014 | 15076 | 0.110 |
Why?
|
Female | 37 | 2021 | 380194 | 0.100 |
Why?
|
Qi | 1 | 2011 | 15 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1257 | 0.100 |
Why?
|
Geriatrics | 1 | 1996 | 396 | 0.100 |
Why?
|
Toes | 1 | 2012 | 206 | 0.100 |
Why?
|
Tendons | 1 | 2016 | 548 | 0.100 |
Why?
|
Reoperation | 1 | 2021 | 4201 | 0.100 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12959 | 0.100 |
Why?
|
Boston | 7 | 2019 | 9313 | 0.100 |
Why?
|
Lactose Intolerance | 1 | 2010 | 27 | 0.090 |
Why?
|
Indium | 1 | 1990 | 46 | 0.090 |
Why?
|
Patient Education as Topic | 2 | 2011 | 2278 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2046 | 0.090 |
Why?
|
Control Groups | 1 | 2010 | 105 | 0.090 |
Why?
|
Indium Radioisotopes | 1 | 1990 | 118 | 0.090 |
Why?
|
Analgesics | 1 | 2017 | 1040 | 0.090 |
Why?
|
Hyperuricemia | 1 | 2012 | 211 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2018 | 2282 | 0.090 |
Why?
|
Activities of Daily Living | 3 | 2019 | 2418 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3778 | 0.080 |
Why?
|
Chenodeoxycholic Acid | 1 | 2008 | 34 | 0.080 |
Why?
|
Risk Assessment | 3 | 2019 | 23338 | 0.080 |
Why?
|
Disabled Persons | 2 | 2018 | 1212 | 0.080 |
Why?
|
Hydrotherapy | 1 | 2008 | 6 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 2 | 2018 | 1855 | 0.080 |
Why?
|
Bacteria | 1 | 2019 | 2114 | 0.080 |
Why?
|
Cathartics | 1 | 2009 | 125 | 0.080 |
Why?
|
Antilymphocyte Serum | 1 | 1989 | 492 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15540 | 0.080 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1578 | 0.080 |
Why?
|
Accidental Falls | 2 | 2018 | 1062 | 0.070 |
Why?
|
Orthotic Devices | 1 | 2008 | 128 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.070 |
Why?
|
Sepsis | 2 | 2020 | 2593 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6489 | 0.070 |
Why?
|
Delayed-Action Preparations | 1 | 2010 | 968 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 804 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1599 | 0.070 |
Why?
|
Organ Specificity | 1 | 2011 | 2008 | 0.070 |
Why?
|
Joint Diseases | 1 | 1990 | 480 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39050 | 0.070 |
Why?
|
Seasons | 1 | 2011 | 1493 | 0.060 |
Why?
|
Prevalence | 6 | 2019 | 15226 | 0.060 |
Why?
|
Risk Factors | 10 | 2020 | 72290 | 0.060 |
Why?
|
Face | 1 | 2011 | 994 | 0.060 |
Why?
|
Irritable Bowel Syndrome | 1 | 2010 | 445 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1222 | 0.060 |
Why?
|
Brain | 1 | 2011 | 26385 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1831 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
Medical Records | 2 | 2002 | 1413 | 0.060 |
Why?
|
Abdomen | 1 | 2010 | 1118 | 0.060 |
Why?
|
Opportunistic Infections | 1 | 2007 | 389 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4669 | 0.060 |
Why?
|
Physical Therapy Modalities | 1 | 2008 | 550 | 0.060 |
Why?
|
Acetaminophen | 2 | 2018 | 545 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2009 | 1184 | 0.060 |
Why?
|
Rhinitis | 1 | 2011 | 691 | 0.060 |
Why?
|
Resuscitation | 1 | 1988 | 658 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11031 | 0.060 |
Why?
|
Neurosecretory Systems | 1 | 2004 | 231 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 2009 | 1182 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2010 | 782 | 0.050 |
Why?
|
Diet | 1 | 2021 | 7939 | 0.050 |
Why?
|
Silicones | 1 | 2003 | 250 | 0.050 |
Why?
|
Acupuncture | 1 | 2002 | 90 | 0.050 |
Why?
|
Adult | 12 | 2022 | 214055 | 0.050 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2011 | 1004 | 0.050 |
Why?
|
Plants, Medicinal | 1 | 2002 | 167 | 0.050 |
Why?
|
Biopsy | 2 | 2006 | 6756 | 0.050 |
Why?
|
Cohort Studies | 7 | 2018 | 40561 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 418 | 0.050 |
Why?
|
Quality of Life | 3 | 2018 | 12804 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4933 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10262 | 0.050 |
Why?
|
Obesity | 2 | 2015 | 12745 | 0.050 |
Why?
|
Physical Examination | 2 | 2009 | 1237 | 0.050 |
Why?
|
Chlorthalidone | 1 | 2020 | 19 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2007 | 810 | 0.050 |
Why?
|
Lisinopril | 1 | 2020 | 54 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2003 | 592 | 0.050 |
Why?
|
Amlodipine | 1 | 2020 | 83 | 0.040 |
Why?
|
Atenolol | 1 | 2020 | 100 | 0.040 |
Why?
|
Pregnancy Outcome | 1 | 2009 | 2795 | 0.040 |
Why?
|
Motor Activity | 1 | 2009 | 2714 | 0.040 |
Why?
|
Incidence | 2 | 2019 | 20947 | 0.040 |
Why?
|
Attitude to Health | 1 | 1988 | 2052 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2022 | 651 | 0.040 |
Why?
|
Safety | 1 | 2003 | 1186 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11727 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 63114 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2003 | 556 | 0.040 |
Why?
|
Prognosis | 3 | 2017 | 29063 | 0.040 |
Why?
|
Vitamin E | 1 | 2022 | 869 | 0.040 |
Why?
|
Medical History Taking | 1 | 2002 | 783 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8664 | 0.040 |
Why?
|
Knee | 1 | 2019 | 274 | 0.040 |
Why?
|
Olecranon Process | 1 | 2017 | 16 | 0.040 |
Why?
|
Dementia | 1 | 2011 | 2518 | 0.040 |
Why?
|
Central Nervous System | 1 | 2004 | 1357 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2003 | 1205 | 0.040 |
Why?
|
Weight Loss | 1 | 2008 | 2622 | 0.030 |
Why?
|
Israel | 1 | 2018 | 796 | 0.030 |
Why?
|
United States | 5 | 2021 | 69872 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 1999 | 432 | 0.030 |
Why?
|
ROC Curve | 2 | 1996 | 3527 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2003 | 1584 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2021 | 2029 | 0.030 |
Why?
|
Hospitals, University | 1 | 2017 | 571 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 365 | 0.030 |
Why?
|
Patella | 1 | 2017 | 320 | 0.030 |
Why?
|
Societies, Medical | 2 | 2015 | 3743 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3870 | 0.030 |
Why?
|
Suburban Population | 1 | 2014 | 55 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 1988 | 3229 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2018 | 253 | 0.030 |
Why?
|
Diphtheria Toxin | 1 | 1995 | 255 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1999 | 719 | 0.030 |
Why?
|
Polypharmacy | 1 | 2017 | 294 | 0.030 |
Why?
|
Urinary Incontinence | 1 | 2018 | 496 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1622 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4149 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 1133 | 0.030 |
Why?
|
Shock, Septic | 1 | 2019 | 775 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 1989 | 10180 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2886 | 0.030 |
Why?
|
Comorbidity | 3 | 2011 | 10388 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1996 | 1179 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 9959 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18370 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2022 | 12026 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3297 | 0.020 |
Why?
|
Pelvic Bones | 1 | 1992 | 265 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2009 | 25625 | 0.020 |
Why?
|
Gait | 1 | 2014 | 793 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1451 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1995 | 1904 | 0.020 |
Why?
|
General Surgery | 1 | 2020 | 1636 | 0.020 |
Why?
|
Spinal Stenosis | 1 | 2011 | 255 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 1681 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 29144 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 56430 | 0.020 |
Why?
|
Liver | 1 | 2003 | 7474 | 0.020 |
Why?
|
Synovial Membrane | 1 | 1990 | 507 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2647 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3313 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2670 | 0.020 |
Why?
|
Odds Ratio | 2 | 2009 | 9849 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 2011 | 793 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Primary Health Care | 1 | 2003 | 4558 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 5102 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1990 | 1588 | 0.020 |
Why?
|
Consensus | 1 | 2015 | 2959 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2021 | 0.020 |
Why?
|
Sarcoidosis | 1 | 1992 | 506 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2011 | 685 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13881 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1990 | 2031 | 0.020 |
Why?
|
Chronic Disease | 2 | 2011 | 9146 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8642 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6459 | 0.020 |
Why?
|
Ankle Joint | 1 | 2009 | 411 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8554 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2002 | 19905 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2971 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4215 | 0.010 |
Why?
|
Patient Readmission | 1 | 2017 | 3114 | 0.010 |
Why?
|
Research Design | 1 | 1999 | 5987 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 1992 | 1848 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4468 | 0.010 |
Why?
|
Disclosure | 1 | 1988 | 736 | 0.010 |
Why?
|
Walking | 1 | 2009 | 1180 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2007 | 639 | 0.010 |
Why?
|
Informed Consent | 1 | 1988 | 995 | 0.010 |
Why?
|
Radiography | 2 | 1992 | 7023 | 0.010 |
Why?
|
Health Surveys | 1 | 2011 | 4037 | 0.010 |
Why?
|
Lung Diseases | 1 | 2011 | 1886 | 0.010 |
Why?
|
Colonoscopy | 1 | 2009 | 1367 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3674 | 0.010 |
Why?
|
Decision Making | 2 | 1999 | 3887 | 0.010 |
Why?
|
Knee Joint | 1 | 2009 | 1680 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2009 | 2050 | 0.010 |
Why?
|
Depression | 1 | 2018 | 7766 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1996 | 21746 | 0.010 |
Why?
|
Heart Diseases | 1 | 2011 | 2788 | 0.010 |
Why?
|
Professional Practice | 1 | 1999 | 326 | 0.010 |
Why?
|
Information Systems | 1 | 1999 | 410 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 12720 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1999 | 795 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 1999 | 603 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4420 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5751 | 0.010 |
Why?
|
Osteosclerosis | 1 | 1992 | 39 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25043 | 0.010 |
Why?
|
Bone Diseases | 1 | 1992 | 416 | 0.000 |
Why?
|
Lymphocytes | 1 | 1995 | 2617 | 0.000 |
Why?
|
Antibodies | 1 | 1995 | 2460 | 0.000 |
Why?
|
Spinal Diseases | 1 | 1992 | 538 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1995 | 3772 | 0.000 |
Why?
|
Prospective Studies | 1 | 1990 | 53288 | 0.000 |
Why?
|
Antigens, CD | 1 | 1995 | 4026 | 0.000 |
Why?
|
Pilot Projects | 1 | 1995 | 8324 | 0.000 |
Why?
|
Adolescent | 1 | 1995 | 85781 | 0.000 |
Why?
|